Indications, Techniques, and Outcomes of Bridge-Enhanced ACL Restoration (BEAR).

IF 3.9 2区医学 Q1 ORTHOPEDICS Current Reviews in Musculoskeletal Medicine Pub Date : 2025-04-01 Epub Date: 2025-02-12 DOI:10.1007/s12178-025-09950-1

Aakash K Shah, Ava G Neijna, Julia S Retzky, Andreas H Gomoll, Sabrina M Strickland

{"title":"Indications, Techniques, and Outcomes of Bridge-Enhanced ACL Restoration (BEAR).","authors":"Aakash K Shah, Ava G Neijna, Julia S Retzky, Andreas H Gomoll, Sabrina M Strickland","doi":"10.1007/s12178-025-09950-1","DOIUrl":null,"url":null,"abstract":"Purpose of review: The current landscape of treating anterior cruciate ligament (ACL) tears is rapidly evolving with the advent of the bridge-enhanced ACL restoration (BEAR). BEAR is a novel approach to restore the ACL in lieu of conventional reconstruction. BEAR has recently been approved for post-market use by all orthopaedic surgeons for midsubstance or proximal ACL tears. This article provides a review of the indications and outcomes of BEAR, graduating from the Trial 1 stage to the post-market stage, current operative techniques, and the postoperative rehabilitation protocol for BEAR.Recent findings: Current research demonstrates similar postoperative patient-reported outcome measures and functional outcomes following BEAR compared to ACL reconstruction in clinical trials. Combining all three BEAR trials, there was an aggregate re-tear rate of 15%. Our post-market published BEAR data shows non-inferior short-term postoperative PROMs and functional outcomes as well as zero re-tears. The early- and mid-term results of BEAR show that it is a potential alternative to ACLR for specific patient groups.","PeriodicalId":10950,"journal":{"name":"Current Reviews in Musculoskeletal Medicine","volume":" ","pages":"140-148"},"PeriodicalIF":3.9000,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11965036/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Current Reviews in Musculoskeletal Medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s12178-025-09950-1","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/2/12 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"ORTHOPEDICS","Score":null,"Total":0}

引用次数: 0

Abstract

Purpose of review: The current landscape of treating anterior cruciate ligament (ACL) tears is rapidly evolving with the advent of the bridge-enhanced ACL restoration (BEAR). BEAR is a novel approach to restore the ACL in lieu of conventional reconstruction. BEAR has recently been approved for post-market use by all orthopaedic surgeons for midsubstance or proximal ACL tears. This article provides a review of the indications and outcomes of BEAR, graduating from the Trial 1 stage to the post-market stage, current operative techniques, and the postoperative rehabilitation protocol for BEAR.

Recent findings: Current research demonstrates similar postoperative patient-reported outcome measures and functional outcomes following BEAR compared to ACL reconstruction in clinical trials. Combining all three BEAR trials, there was an aggregate re-tear rate of 15%. Our post-market published BEAR data shows non-inferior short-term postoperative PROMs and functional outcomes as well as zero re-tears. The early- and mid-term results of BEAR show that it is a potential alternative to ACLR for specific patient groups.

Abstract Image

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

桥式增强ACL修复（BEAR）的适应症、技术和结果。

回顾目的：随着桥式增强前交叉韧带修复术（BEAR）的出现，目前治疗前交叉韧带（ACL）撕裂的方法正在迅速发展。BEAR是一种代替传统重建重建前交叉韧带的新方法。BEAR最近已被所有矫形外科医生批准上市后用于中物质或近端ACL撕裂。本文综述了BEAR的适应症和结果，从试验1阶段到上市后阶段，目前的手术技术，以及BEAR的术后康复方案。最近的发现：目前的研究表明，与临床试验中ACL重建相比，BEAR术后患者报告的结果和功能结果相似。结合所有三个BEAR试验，总再撕裂率为15%。我们上市后公布的BEAR数据显示，术后短期PROMs和功能结果良好，无再撕裂。BEAR的早期和中期结果表明，对于特定的患者群体，它是ACLR的潜在替代方案。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文去求助

来源期刊

Current Reviews in Musculoskeletal Medicine ORTHOPEDICS-

CiteScore

7.50

自引率

2.40%

发文量

期刊介绍： This journal intends to review the most significant recent developments in the field of musculoskeletal medicine. By providing clear, insightful, balanced contributions by expert world-renowned authors, the journal aims to serve all those involved in the diagnosis, treatment, management, and prevention of musculoskeletal-related conditions. We accomplish this aim by appointing authorities to serve as Section Editors in key subject areas, such as rehabilitation of the knee and hip, sports medicine, trauma, pediatrics, health policy, customization in arthroplasty, and rheumatology. Section Editors, in turn, select topics for which leading experts contribute comprehensive review articles that emphasize new developments and recently published papers of major importance, highlighted by annotated reference lists. We also provide commentaries from well-known figures in the field, and an Editorial Board of more than 20 diverse members suggests topics of special interest to their country/region and ensures that topics are current and include emerging research.